Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial
Year: 2005
Type: article
Study design: Clinical Trial
Source: Clinical Therapeutics
Authors: Aaron I. Vinik, Vera Bril, Peter Kempler, William J. Litchy, Solomon Tesfaye, Karen L. Price, Edward J. Bastyr
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2001129294
